Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia, Myelomonocytic, Chronic
×
tipifarnib
×
Clear all
Filters
3
NCT02807272
2024-07-17
CMML/AML
Kura Oncology, Inc.
Phase 2
Completed
44 enrolled
17 charts